Latest News

  • Galatea Bio, Fabric Genomics Combine Pathogenic Variant Analysis with Polygenic Risk Score

    Diagnostics World | Galatea Bio and Fabric Genomics announced a strategic collaboration this week to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

    Jun 26, 2025
  • Follow the Money: Neuroplastogens Novel Therapies, Genetic Medicines, More

    Diagnostics World | Elkedonia SAS plans to develop the drug-like small molecule inhibitors of Elk1, a novel intracellular target that plays a pivotal role in reward brain circuits and neuroplasticity; SpliceBio will advance the clinical development of their lead gene therapy candidate, SB-007, for Stargardt disease; and more.

    Jun 25, 2025
  • Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More

    Diagnostics World | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.

    Jun 24, 2025
  • Nanoneedle Technology Could Transform Medical Diagnostics

    Diagnostics World | Researchers at King's College London have developed a diagnostic tool that could enable doctors to sample tissue during critical medical procedures. The nanoneedle patch technology enables physicians to extract molecular information from living tissue without causing damage or killing cells—a capability that could prove especially valuable in delicate surgical situations.

    Jun 20, 2025
  • Real-time Molecule Monitoring Could Put an End to ‘Reactive Medicine’

    Diagnostics World | Modern jet engines can generate a terabyte or more of data per hour that gets transmitted back to the engine manufacturer to ensure aircraft safety and prevent disasters from happening. Yet the human body, arguably the most important machinery of them all, gets checked only once a year or whenever something has already gone wrong.

    Jun 17, 2025
  • Myeloma Diagnostics: Ultra-Sensitive Detection and Population-Scale Screening Transform Disease Management

    Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics.

    Jun 12, 2025
  • Pharmacogenomic Testing Shows Value in Improving Prescribing Precision

    Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice.

    Jun 11, 2025
  • Endometriosis Developments: Newly Launched Tests and Treatment Updates

    Diagnostics World | Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. The condition is painful, can impede fertility, and is difficult to diagnose. But a host of new tools seek to improve diagnostics and treatment for the condition.

    Jun 10, 2025
  • Genetic Diagnostics Find Common Ground Between ME/CFS, Long COVID

    Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations.

    Jun 5, 2025
  • After More Than Four Decades, a Third Subtype of Castleman Disease Found

    Diagnostics World | A new subtype of Castleman disease has been identified, the first such major discovery in 45 years. While it remains unclear how many individuals stand to benefit, this is a “hugely important” development for the proportion of patients who fit neither the “unicentric” nor “multicentric” criteria long used to describe the symptoms and disease experience.

    Jun 3, 2025
  • Follow the Money: Deepull’s Diagnostic System, Gestalt Expands Pathology Platform, More

    Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.

    May 30, 2025
  • Microsoft, iCAD Collaboration, Revvity Launches New Platform, More

    Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.

    May 29, 2025
  • Smart Bandage for Monitoring Chronic Wounds Moves from Mice to Humans

    Diagnostics World | Parallel developments in wearable sensors, microfluidics, and machine learning have enabled the first-time use of a “smart bandage” in 20 human patients with chronic wounds. The latest version of the bandage, referred to as iCares, was showcased in a new study where fresh fluid from injured tissue was continually sampled to classify wound severity and healing potential.

    May 28, 2025
  • The Diagnostic Dilemma: Addressing Errors in Modern Healthcare

    Diagnostics World | Diagnostic errors remain a persistent and costly challenge in healthcare worldwide, leading to significant patient harm and financial burden. Despite advances in medical technology and research, these errors—missed, delayed, or incorrect diagnoses—cause thousands of preventable deaths and billions in healthcare costs each year.

    May 23, 2025
  • Applying Genomics Beyond Cancer

    Diagnostics World | Genomics has led to phenomenal scientific and medical advances over the last several decades, especially in cancer care. This progress can be seen not only in personalized therapies and drug development, but also in the ability to use biomarkers to identify the right drug for the right patient at the right time.

    May 16, 2025
  • Comparison of AI Digital Pathology Tools Finds Means to Measure Performance

    Diagnostics World | In a research project comparing the performance of 10 digital pathology tools capable of evaluating HER2 status from a common set of about 1,100 breast cancer samples, a key finding was the high level of agreement between their results and those of expert human pathologists—at least when the tumor marker was highly expressed.

    May 15, 2025
  • Protecting Clinical Labs in the Crossfire of Health Policy Debates

    Diagnostics World | For diagnostic labs, 2025 is a “big, complicated year” that began with a milestone “win” for laboratories when a U.S. District Court decision vacated a Food and Drug Administration (FDA) final rule that would have regulated all laboratory-developed tests (LDTs) as medical devices. Despite that win, there is no shortage of concerns and challenges facing the industry, including unknowns about the final shape of the federal reconciliation package on Capitol Hill.

    May 13, 2025
  • ‘Better Stethoscope’ Could be First Step in Diagnosing Heart Valve Disease

    Diagnostics World | The stethoscope, despite being more than 200 years old, is not an easily retired diagnostic device. It remains symbolic of the medical profession, even if many physicians no longer wear them and those that do are not particularly good at using them.

    May 8, 2025
  • Saliva Test Could Help Oncologists Know When to Avoid Common Cancer Drug

    Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.

    May 6, 2025
  • By Focusing on Nearer-Term Incremental Change, We Can Pave the Way to Multi-Cancer Early Detection Tests

    Diagnostics World | One of the most important tools we have to reduce mortality from cancer is early detection. Mammograms have had a significant impact in improving outcomes for patients with breast cancer, and colonoscopies have done the same for patients with colorectal cancer. But despite broad recognition of the importance of early cancer detection, our ability to screen for a wide range of cancers is quite limited. In fact, there are only five cancers for which Medicare is directed to pay for screening: breast, cervical, colon, lung, and prostate.

    May 2, 2025